Ovation Science stock analysis
Ovation Science (0VH) Stock Price & Analysis
0VH Stock Chart & Stats
- Day’s Range
- EUR 0.01 - EUR 0.01
- 52-Week Range
- EUR 0.01 - EUR 0.02
- Previous Close
- EUR 0.01
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 485.15K
- Enterprise Value
- EUR 855.55K
- Total Cash (Recent Filing)
- EUR 13.22K
- Total Debt (Recent Filing)
- EUR 292.14K
- Price to Earnings (P/E)
- ―
- Beta
- 1.13
- Next Earnings
- Nov 30, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Focused Topical-product Model
A focused product model gives the company a clear commercial direction in topical personal care and skin health. Concentrating resources on a defined application area can support disciplined product development and brand positioning over the next several quarters.
Proprietary Delivery Technology
Proprietary transdermal delivery approaches may provide a basis for product differentiation if they improve how active ingredients are applied or absorbed. This technology-centered positioning could support commercialization and customer interest beyond a commodity topical offering.
Improved Cash-burn Discipline
Material improvement in cash burn versus prior years indicates some cost containment and better operating discipline. Although cash generation remains negative, a lower rate of outflow can extend financial runway and create more time to improve products, sales, and profitability.
Bears Say
Persistent Unprofitability
Persistent losses and a return to negative gross profit indicate that the current business model has not established stable unit economics. Without sustained gross margins, revenue growth is less likely to convert into earnings and the company may struggle to fund development internally.
Negative Equity And Solvency Pressure
Negative stockholders’ equity is a significant balance-sheet weakness because liabilities exceed recorded assets. Combined with existing debt, this reduces financial flexibility and raises the likelihood that continued losses could require recapitalization or shareholder dilution.
Dependence On External Financing
Recurring negative operating and free cash flow means the business does not currently fund its operations from internally generated cash. Continued cash deficits can constrain investment in commercialization and increase reliance on external financing to sustain operations.
0VH FAQ
What was Ovation Science’s price range in the past 12 months?
What is Ovation Science’s market cap?
When is Ovation Science’s upcoming earnings report date?
How were Ovation Science’s earnings last quarter?
Is Ovation Science overvalued?
Does Ovation Science pay dividends?
What is Ovation Science’s EPS estimate?
How many shares outstanding does Ovation Science have?
What happened to Ovation Science’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Ovation Science?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Ovation Science
Ovation Science Inc. specializes in the creation of cannabis and hemp-based products, distributed across Canada, the United States, and Mexico. A cornerstone of its offerings is Invisicare, a patented drug delivery technology employed in topical and transdermal skincare formulations. This system integrates hemp seed oil and cannabis, underpinning the company's Ovation and BASKiN brands. Additionally, Ovation Science provides a diverse product portfolio including Invibe MD for CBD-infused health and wellness, ARLO CBD for skincare, and DermSafe for hand sanitizers. The company possesses sublicenses for its cannabis product lines and utilizes its Lighthouse initiative to engage with licensed dispensaries throughout the United States. Founded in 2017, Ovation Science Inc. is based in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Terry H. Howlett
- Employees
- 5
- Website
- ovationscience.com
- Address
- 1003-1166 Alberni Street, Vancouver, BC, V6E 3Z3, CA
Ovation Science (0VH) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 4 | 9 |
| Technical Analysis | 0 | 2 | 2 |
| Moving Averages | 1 | 2 | 7 |








